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GarethNye joined theMaternal and Fetal Health Research Centre in 2017 having worked previously
on trials improving functionality and oxygen availability in the musculoskeletal system at advanced
age. Following his PhD thesis, his work focused on applying these practices to the placenta and
materno-fetal interactions. Recent work has focused on relating placental oxygenation levels with
advanced structural and functional approaches. Paul Brownbill, in a preliminary study of human
placental permeability, discovered an important paracellular route in the maternal blood-facing
epithelium, occurring through a natural denudation–repair mechanism in the syncytiotrophoblast.
This was in collaborationwith Professors Sibley, Nelson andThornburg.His attention then turned to
the regulation of fetoplacental vascular blood flow and in 2007 his PhD thesis described a pleiotropic
role for agonists evoking changes in vascular tone, additionally regulating feto-maternal water transfer. His recent works have centred on placental
flow-mediated vasodilatation and oxygen transfer dysregulation in fetal growth restriction.
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Abstract The placenta is crucial for life. It is an ephemeral but complex organ acting as the
barrier interface between maternal and fetal circulations, providing exchange of gases, nutrients,
hormones, waste products and immunoglobulins. Many gaps exist in our understanding of
the detailed placental structure and function, particularly in relation to oxygen handling and
transfer in healthy and pathological states in utero. Measurements to understand oxygen transfer
in vivo in the human are limited, with no general agreement on the most appropriate methods.
An invasive method for measuring partial pressure of oxygen in the intervillous space through
needle electrode insertion at the time of Caesarean sections has been reported. This allows
for direct measurements in vivo whilst maintaining near normal placental conditions; however,
there are practical and ethical implications in using this method for determination of placental
oxygenation. Furthermore, oxygen levels are likely to be highly heterogeneouswithin the placenta.
Emergingnon-invasive techniques, such asMRI, and ex vivo research are capable of enhancing and
improving current imagingmethodology for placental villous structure and increase the precision
of oxygen measurement within placental compartments. These techniques, in combination with
mathematical modelling, have stimulated novel cross-disciplinary approaches that could advance
our understanding of placental oxygenation and its metabolism in normal and pathological
pregnancies, improving clinical treatment options and ultimately outcomes for the patient.
(Received 28 November 2017; accepted after revision 18 January 2018; first published online 26 January 2018)
Corresponding author G. A. Nye: Maternal and Fetal Health Research Centre, Institute of Human Development,
University of Manchester, Manchester M13 9WL, UK. Email: gareth.nye@manchester.ac.uk
Abstract figure legend There are a range of techniques to assess structure and function in the placenta. These techniques
vary widely in resolution and accuracy in particular when assessing a crucial placental function, measuring oxygen
levels. Very few techniques can study both structure and function to any high detail and so mathematical modeling has
bridged the gap. However, the strength of the model relies entirely on the strength of the data gained from experimental
procedures.
Introduction
The placenta is vital for fetal growth and development,
adapting its physiology, architecture and signalling
throughout gestation to meet changing demands. Despite
this, there remain many unanswered questions in our
detailed understanding of placental structure, function
and transfer efficacy in both normal and diseased states
in utero.
It is an ephemeral but complex organ acting as the
interface between mother and fetus, providing a hub
for exchange. One of the key functions of the placenta
is to mediate transfer of oxygen to the fetus. However,
there is poor consensus on the oxygenation of placental
compartments, most notably oxygen gradients within the
intervillous space (IVS) of the maternal circulation, and
how the partial pressure of this gas (PO2) differs between
normal pregnancies and those complicated by placental
diseases. A full understanding of spatio-temporal
oxygenation and associated placental villous architecture
in healthy and diseased states, aiding mathematical model
development on transplacental oxygen transfer, will
ultimately be useful to obstetricians trying to understand
and treat placental disease. In this review, we will
present current views on human placenta structure and
function with respect to oxygen transfer. This will include
discussions on the strengths andweaknesses of the current
methods used to measure placental oxygenation both
in vivo and ex vivo. It will also summarise reported oxygen
levels within the placenta–fetal unit, with an emphasis on
dysregulated materno-fetal oxygen transfer in pregnancy
pathologies.
Placental structure and function
The human placenta is a discoid haemomonochorial
dually perfused organ, which in a healthy term pregnancy
has a mean mass of 650 g and a surface area for
exchange of 13 m2 (Mayhew et al. 2007). It contains 25%
(80 mL) of the total fetal blood volume (Luckhardt et al.
1996). Fetal blood flow from the two umbilical arteries
is forced through two elaborately branched networks
across the chorionic plate before delving into the placental
mass where they branch again entering approximately 50
placental villous trees. Several villous trees might occupy
a single lobule, which is the semi-compartmentalised
structure defined by septa as seen from the basal plate
aspect. Villous trees are elaborately branched, com-
mencing with stem villi (Leiser et al. 1985). Stem villi
divide extensively to form intermediate villi, with the
mature type branching off to form the terminal villi
(Kaufmann et al. 1985). In later pregnancy, having arrived
at the villous capillaries via an arteriolar microcirculatory
system, the fetoplacental capillary blood enriched with
oxygen and nutrients is forced into the venular systems of
themature intermediate and stem villi, and then into veins
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on the chorionic plate, subsequently travelling to the fetus
via a single umbilical vein. Architectural events unfold in
the developing placenta throughout gestation to arrive at
the position of mature villous trees capable of servicing
the ever-increasing demand of the fetus for oxygen. See
e.g. Huppertz (2008) and Wang and Zhao (2010) for the
detailed anatomy and physiology of the human placenta
and its developmental aspects.
During the third trimester, terminal villi formation
increases exponentially (Risau & Rubanyi, 2000). From
24 to 26 weeks of gestation, branching angiogenesis
ensues, leading to capillary outgrowths and the matu-
ration of intermediate villi. Capillary loops are hypo-
thesised to dilate and remodel laterally under trans-
mural hydrostatic pressure between the fetal and
maternal placental circulations (Burton et al. 1996).
Furthermore, fetal and maternal blood are brought
into close proximity at specialised adaptive capillary
structures known as vasculosyncytial membranes. These
represent a thinning of the combined fetoplacental end-
othelium and syncytialised trophoblast, with extensive
lateral displacement of single-celled trophoblasts and
membrane-associated organelles (Castellucci et al. 1990).
This structural adaptation confines the endo-epithelial
placental barrier to a diffusion distance of 2–3 μm, an
important facet of Fick’s law of diffusion, appertaining
more particularly to the efficiency of transfer of hydro-
philic molecules (Sibley et al. 1998), but also in part to fast
diffusing gases like oxygen. The pathway of blood between
the placenta and fetus with compartmentalised reported
oxygen ranges in late pregnancy has been summarised for
the purpose of this review in Fig. 1.
Although the placenta is involved in essential functions
to maintain fetal health, little is known about how human
placenta transfer in vivo relates to fetal oxygen acquisition
in the human. The placenta is dynamic, with the capability
of adapting to possible net reductions in maternal blood
flow, ensuring there is an adequate supply of oxygen to
the fetus (Wilkening & Meschia, 1983). In vivo work
using animal models, most notably the sheep, shows a
normal tolerance to reducedmaternal-sideplacental blood
flow, before placental metabolic demands out-compete
fetal demands for oxygen provision from the maternal
circulation (Gu et al. 1985). The work of Gu, who
collaborated with Professor Julian Parer whilst he was at
the University of California, showed that a reduction in
uterine artery blood flow by up to 30% had no effect
on fetal oxygenation levels (Gu et al. 1985). Whilst the
anatomy of the sheep placenta is substantially different
to the human placenta, broader concepts such as hypo-
xic fetoplacental vasoconstriction and the possible role of
oxygen-sensitive voltage-gated potassium channels in this
process, as found inhumans,might provide a cross-species
mechanism by which feto-maternal blood flow matching
could arise (Byrne et al. 1997; Hampl et al. 2002; Kiernan
et al. 2010).
Modern in vivo imaging, ex vivo placental spatial
oxygen mapping technology andmathematical modelling
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Figure 1. Simplified schematic diagram of the maternal and fetal placental circulations, showing the
major compartments and published attributed in vivo oxygen values (see Table 1)
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are now available to investigate these early observations
and aim to unravel the intricacies of how fetal oxygen
acquisition is regulated by placental structure and
function in health and disease. This multidisciplinary
approach has shown the impact of sinusoidal capillaries
on placental function (Pearce et al. 2016; Plitman Mayo
et al. 2016b) where mathematical modelling indicates
the existence of an optimal capillary dilatation size that
maximises oxygen uptake. A fuller understanding of the
remaining aspects of the placental oxygen transfer in
health and disease now seems possible.
Oxygen metabolism and levels within
the human placenta
In the placenta, gases diffuse due to partial pressure
gradients which are maintained by maternal and fetal
blood flow. As diffusion of gases across the placenta
is rapid, placental gas transfer is flow limited (Meschia
et al. 1967). Oxygen transfer depends on a partial
pressure gradient being present between the maternal
blood in the intervillous space (IVS) and the fetal blood
in the fetoplacental capillaries and is enhanced by the
Bohr–Haldane effect: as maternal blood takes up fetal
carbon dioxide and becomes acidotic, oxygen release to
the fetus is favoured. Simultaneously fetal blood takes up
oxygen while decreasing its storage capacity for carbon
dioxide and releasing it into the maternal circulation
(Pinnock et al. 2002).Additionally, there is a higher affinity
of the fetal haemoglobin for oxygen, fetal haemoglobin
containing two α and two γ subunits compared to
maternal haemoglobin which has two α and two β sub-
units.When considering oxygen levels within the placenta,
the differing compartments need to be viewed separately.
The normal range for oxygenation of adult blood is
between75 and100mmHg.Although theremaybe a slight
reduction in this during pregnancy, it is not expected to
differ greatly. IVS soluble oxygenation values are expected
to be reduced by the metabolic demand of placental
tissue and the transfer to the fetal circulation. It is known
that 40% of the total oxygen consumption occurs in the
syncytiotrophoblast layer (Carter, 2000). However, where
there is failure of spiral arteries to transform to a wider
aperture, this potentially leads to altered haemodynamics,
with a reduced net IVS flow, more localised blood flow
patterns, and disparate skewed oxygen gradients around
placental villi (Burton et al. 2009). This in turn ultimately
leads to placental dysfunction and disease.
Poor placental oxygenation – a trigger for
placental dysfunction
The placenta is developed tomaximise the transfer of gases
andnutrients to aid the growthof the fetus.When this fails,
awide rangeofmaternal and fetal complications canoccur,
one of themost common complications being fetal growth
restriction (FGR) where the fetus fails to reach its genetic
growth potential. Over half of neonatal deaths worldwide
are associated with low birth weight (UNICEF, 2004).
Surviving FGRneonates face developmental problems and
an increased risk of cardiovascular diseases in later life.
There are many causes of FGR involving both maternal
and placental factors (Sharma et al. 2016). One key factor
is a reduction in oxygen transfer to the baby. Placentas
measured from FGR babies are on average 24% smaller in
weight than normal pregnancies (Heinonen et al. 2001).
In the absence of genetic abnormalities and underlying
maternal conditions, this suggests a reduced functional
capacity of the placenta. One hypothesised aetiology
is a reduced placental surface area for gas exchange,
coupled with dysregulated placental blood flow, leading
to suboptimal oxygen transfer from maternal to fetal
circulations (Yu, 1992). An alternative aetiology is that
dysregulated placental morphology might also reduce
the oxygen transfer across the placenta. Non-placental
aetiologies relate to maternal lifestyle factors which
include smoking, living at high altitude and heart or
lung disease, all of which depress the PO2 in the maternal
circulation, diminishing placental oxygen transfer
(Sharma et al. 2016). In such low oxygen environments,
as found in some cases of FGR, it should be borne inmind
that placental metabolism might shift to a high glucose
and low oxygen consumption mode, which could have
a bearing on relative oxygen transfer rates to the fetus.
This indirect evidence comes from an analogous study of
high altitude pregnancies, referring to a reduced maternal
oxygen supply to the placenta (Zamudio et al. 2010).
Conversely, Kingdom et al. proposed processes
whereby changing oxygen levels can alter the structure of
capillarisation within the terminal villous tree (Kingdom
et al. 2000).Potentially this cancompoundanalready com-
promised disturbance in PO2 , further reducing oxygena-
tion of the fetal circulation. The hypothesis remains to be
tested that compromised villous tree architecture coupled
with existing reduced oxygen levels in the maternal
circulation exceeds a critical threshold leading to FGR.
A comprehensive study including mathematical
modelling of complex placental architecture, coupled
with ex vivo physiological perfusion experimentation and
in vivo magnetic resonance imaging (MRI), will provide
further answers. This may then permit an interrogation
of transplacental transfer efficacy of oxygen, providing
translational tools for obstetricians in their diagnosis
and management of FGR associated with oxygen transfer
deficiency.
Current understanding of placental oxygen levels
As discussed previously, the in vivo measurement of
placental oxygen has proved difficult and has only been
C© 2018 University of Oxford. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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recorded in a handful of studies. Schaaps et al. published
the most recent cross-sectional study (Schaaps et al. 2005)
using IVS blood sampling which was achieved through
insertion of a 21 gauge needle through the chorionic plate,
with blood being collected once the baby was delivered,
but before the placenta was expelled (Schaaps et al. 2005).
This had previously been done in 1960 by Quilligan et al.
and again in 1996 by Fujikura & Yoshida, who both
recorded lower average values. The Schaaps paper also
published a PO2 ratio between the uterine vein and the
IVS of 1.5 (Schaaps et al. 2005). Using this ratio, values of
50 mmHg in the uterine vein (Sibley et al. 2002) would
lead to an approximate IVS value of 33 mmHg. With
near infrared spectroscopy, Kakogawa et al. (2010) pre-
dicted an IVS value of 30 mmHg. Although providing the
best-available estimate of IVSPO2 , cautionmust be applied
to the uterine vein–IVS ratio extrapolator. The ratio first
appears counterintuitive, since uterine vein blood occurs
downstream of the IVS. However, arteriovenous placental
shunting and preferential IVS flow pathways evading
PO2 measurement may lead to higher than expected
uterine vein oxygen values. Ideally, further ubiquitous IVS
real-time data must be sought before relying solely on this
reported ratio.
The few studies recording IVS oxygenation in term
placentas show a value of approximately 36 mmHg.
This is much lower than the PO2 of peripheral maternal
arterial blood, which does not drop below 100 mmHg
throughout gestation (Templeton & Kelman, 1976),
potentially indicating transfer loss and a highly metabolic
cellular layer of the IVS.
Compartmentalised in vivo values of soluble human
placental oxygenation are given in Fig. 1 and cor-
responding published values are summarised in Table 1.
A small reduction in the oxygen levels between the IVS
and the umbilical vein is evident with an average IVS
oxygen recording of 30 mmHg and a further reduction in
values between theumbilical vein andarteries (22mmHg).
However, there is much greater variation in the recorded
values in both measures potentially due to different
experimental methods. In particular, there are differences
in practice regarding clamping of the umbilical cord after
delivery.As shown inTable 1, other studiesmeasuringboth
venous and arterial values from the same cord recorded
similar reductions in the arterial values (Nicolaides et al.
1989; Link et al. 2007). The venous oxygen level recorded
by Schaaps et al. is somewhat lower than other recorded
values and lower than the average value by 10 mmHg,
which is possibly due to the measurement of unclamped
cords influencing the oxygen value (Schaaps et al. 2005).
It is expected that cord clamping will yield results
closer to peripartum PO2 levels, due to cord samples
being compartmentalised away from the highly metabolic
placental tissue.
Measuring and modelling oxygen transfer function
in the human placenta
Assessing function through in vivo electrodes. A
reported method for analysing placental oxygen status
of the IVS is through the insertion of a needle into
the placental tissue during routine Caesarean sections
(Quilligan et al. 1960; Fujikura &Yoshida, 1996) (Table 1).
Although this allows for direct measurement in vivo
whilst still under normal conditions, there is a sampling
efficiency problem due to the limited number of IVS
PO2 measurements that can realistically be taken during
surgery in such a large tissue. The heterogeneity of PO2
levels within the IVS and the potential for contamination
of IVS samples from disruption of the fetal capillaries
are also major problems with this early method. However,
there have been recentmoves towards in vivo techniques to
measure oxygenmoreubiquitously in thehumanplacenta.
Assessing function through magnetic resonance imaging.
MRI techniques have demonstrated the ability to
measure non-compartmentalised changes in oxygen levels
within defined placental spatial parameters. One such
technique, blood-oxygen-level-dependent (BOLD) MRI
(Fig. 2A), can effectively measure changes in placental
oxygen saturation following a maternal oxygen challenge.
Deoxyhaemoglobin acts as an endogenous contrast
agent, due to the differing magnetic properties of
both oxyhaemoglobin and deoxyhaemoglobin. Changes
in oxygen saturation, and therefore deoxyhaemoglobin
levels, alter the local magnetic field susceptibility, thus
affecting transverse relaxation times and BOLD signal.
The first human placental BOLD MRI study (Sorensen
et al. 2013) described results from eight women with
uncomplicated singleton pregnancies at 28–36 weeks’
gestation. An increased BOLD signal was detected in areas
proximal to the chorionic plate of the placenta. However,
the potential application of BOLD in placental pathology
is uncertain with conflicting data concerning FGR pre-
gnancies in early comparative studies (Ingram et al. 2017).
The interpretations of BOLD signal changes is complex
due to its relation to haemoglobin concentration and
potential oxygen-related changes in local perfusion. The
signal is also potentially affected by undetected uterine
activity and there is a tendency for BOLD signal intensity
to be correlated more closely with fetal haemoglobin
oxygen saturation than with maternal haemoglobin
oxygen saturation. This may be due to the relative hypo-
xic condition of the normal fetus, which results in a
significant BOLD signal change, with changes in oxygen
concentration, operating along the exponential phase of
the sigmoidal fetal haemoglobin oxygen association curve.
In addition to BOLD MRI, effective changes in tissue
PO2 have been determined using a complementary
C© 2018 University of Oxford. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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Table 1. In vivo IVS and ex vivo umbilical artery and vein PO2 values in term normal human placentas
PO2 values
a (no.
of samples) Type of measurement Time of measurement Reference
Pre-partum IVS 34 (n = 4) 18 gauge needle Before placental shedding (Quilligan et al. 1960)
30 (n = 12) 21 gauge needle Before placental shedding (Fujikura & Yoshida, 1996)
Post-partum IVS 49 (n = 12) 18 gauge needle N/A (Haruta et al. 1986)
33 (n = 6) Uterine vein analysis Post placental shedding (Sibley et al. 2002)
29 (n = 9) 21 gauge needle (Schaaps et al. 2005)
30 (n = 15) Uterine vein analysis (Kakogawa et al. 2010)
Range 29–49
Weighted mean ± SD 34 ± 9
Umbilical artery 28 (n = 53) Cordocentesis Before Caesarean section (Nicolaides et al. 1989)
18 (n = 681) N/A Post placental shedding (Dudenhausen et al. 1997)
21 (n = 60) 21 gauge needle (Daniel et al. 1998)
30 (n = 18) Blood gas analyser (Ochiai et al. 1999)
16 (n = 1281) N/A (Arikan et al. 2000)
19 (n = 46) N/A (Link et al. 2007)
26 (n = 60) N/A (Fardiazar et al. 2013)
23 (n = 46) N/A (Di Tommaso et al. 2014)
Range 16-30
Weighted mean ± SD 18 ± 4
Umbilical vein 35 (n = 14) Before Caesarean section (Pardi et al. 1987)
43 (n = 143) Cordocentesis (Nicolaides et al. 1989)
31 (n = 60) 21 gauge needle Post placental shedding (Daniel et al. 1998)
18 (n = 18) Blood gas analyser (Ochiai et al. 1999)
19 (n = 9) 21 gauge needle (Schaaps et al. 2005)
25 (n = 46) N/A (Link et al. 2007)
29 (n = 300) N/A (Bernardez-Zapata &
Moreno-Rey, 2014)
27 (n = 46) N/A (Di Tommaso et al. 2014)
Range 19–43
Weighted mean ± SD 32 ± 8
Uterine artery 97 (n = 50) Electrode Post placental shedding (Blechner et al. 1968)
147 (n = 18) Blood gas analyser (Ochiai et al. 1999)
91 (n = 168) (Postigo et al. 2009)
Range 91–147
Weighted mean ± SD 97 ± 22
Uterine vein 33 Electrode Post placental shedding (Stave, 1970)
50 (n = 6) Blood gas analyser (Sibley et al. 2002)
46 (n = 10) 21 gauge needle Before placental shedding (Fujikura & Yoshida, 1996)
Range 33–50
aPO2 values are in mmHg. N/A, not available. Cross-study values are presented as range and mean ± SD, weighted with the sample
size.
technique, oxygen-enhanced (OE) MRI. In OE MRI,
changes in longitudinal relaxation rates (R1) occur due to
an increase in the paramagnetic dissolved oxygen content
in the tissue with maternal hyperoxia. An increase in
R1 following maternal hyperoxia, reflecting an increase
in PO2 , was first demonstrated in the placenta in 2013
(Huen et al. 2013). Increases in R1 following hyper-
oxia diminish with gestational age, which is thought
to be a consequence of rapid materno-fetal O2 trans-
fer and utilisation. Additionally, in pregnancies affected
by FGR, R1 changes are significantly lower presumably
demonstrating a relative placental hypoxia as more of
the dissolved oxygen is bound to deoxyhaemoglobin
(Ingram et al. 2017). The benefit of these techniques
are their non-invasive nature; however, they are limited
in availability and expensive (Sorensen et al. 2013).
Essentially these techniques provide measures of relative
change in tissue oxygen status. However, these techniques
cannot provide absolute PO2 or saturation values without
further phantom validation.
Understanding placental blood flow rates is also
important in deciphering placental oxygen transfer
efficacy. Within in vivo imaging capability, several options
might be available to the researcher in appreciating
C© 2018 University of Oxford. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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flow: dynamic contrast enhanced imaging (DCE) (Marcos
et al. 1997), arterial spin labelling (ASL) (Gowland
et al. 1998) and phase contrast imaging (Jansz et al.
2010). DCE MRI provides spatial images of villous
capillary (fetal) and IVS (maternal) flow. Substances
such as Omniscan (a gadolinium chelate) are unstable
and therefore potentially toxic when used in vivo and
have not been characterised for vascular leakage and
signal stability. They therefore are only suited for ex vivo
perfusions or acute animal experiments. These validations
are essential in proving that acquired flow signals are
truly compartmentalised. The future research agenda in
placenta MRI is optimization of acquisition techniques
and combining MRI approaches, such as OE with ASL, to
fully characterise the placenta.
In ASL, blood is intrinsically labelled, avoiding the
concerns of exogenous contrast agents, and therefore this
technique has been used in vivo to determine placental
flow; however, to date, ASL has been performed on
a placental region-of-interest which incorporates both
maternoplacental and fetoplacental compartments (Shao
et al. 2017).ASLquantifies flowper gramof tissuemass but
the technique is hampered by poor signal-to-noise ratio
and the few studies that have been performed demonstrate
considerable variation in derived normal values.
Whilst functional MRI (fMRI) may be of benefit
through the measurement of placental perfusion and
oxygen status, its use in the placenta is still limited by a lack
of data and there are no accepted MRI-based definitions
of normal/abnormal placental tissue flow rates (Avni et al.
2015). Again, this could be due to differences in cost
and availability but also through a lack of consensus on
protocols, and poor image quality due to the challenges
of correcting for maternal and fetal motion. However,
these MRI techniques could be exploited ex vivo, through
phantom perfusion investigations, utilising the human
dual placental perfusion model to quantify flow and
validate in vivo perfusionmeasures, improving our under-
standing of the imaging response as a proxy to tissue
oxygenation.
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Figure 2. Measuring oxygen distribution in the human placenta
A, demonstrating a normal placenta imaged using oxygen-enhanced (OE) MRI techniques. This shows an axial
T2-weighted structural MR image through maternal abdomen at the level of the uterine cavity (circled in blue)
demonstrating: fetal abdominal cross-section (circled in white) and placental region of interest (circled in red) with
a superimposed delta R1 map. The colour gradient voxels in the dR1 map demonstrate the differing change in
PO2 across the placenta following maternal hyperoxia. B, soluble oxygen measurement of the perfusate in the
maternal-side arterial inflow line and the IVS in the ex vivo dually perfused placental lobule, measured via a pre-IVS
oxygen chamber (flow-through cell) and via an optode needle inserted into the placental tissue, respectively. C, a
close-up image showing the insertion points of both the maternal cannula (i.d. = 2 mm, super-glued into position
to form a seal with the decidua) and the IVS oxygen optode needle inserted through the decidual surface of the
placenta.
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Assessing function through ex vivo placental perfusion.
There is a limited capability to manipulate in vivo physio-
logical variables during human pregnancy. In this stance,
the utilisation of ex vivo physiological research techniques
is now coming to the fore. Ex vivo dual perfusion of
the human placenta is now a widely used system for
investigating a range of pharmacological and physiological
functions including drug transfer whilst maintaining
placental structure and an approximate in vivo state
(Fig. 2B). Perfusion has advantages over cell culture,
tissue slices and explant studies due to the maintenance
of villous architecture and relative IVS volume density
(Brownbill et al. 2018). Vascularised fetoplacental and
IVS perfusate flows are key features of the model in
which the placental tissue maintains a higher metabolic
level than in other human placental models (Hauguel
et al. 1983). This technique involves isolating a whole
placental cotyledon from a freshly delivered placenta. The
fetal side is cannulated on both arterial and venous sides
and either near-anoxic blood or physiological buffer is
pumped through the villous microcirculation (Schneider
& Huch, 1985). The maternal side is also supplied with
blood or physiological buffer at normoxic or superoxic
PO2 levels. [53, 54] Flow rates of perfusate are similar to,
but less than, in vivo conditions (fetal side, 6 mL min−1)
to reduce the overall resistance encountered during the
experiment. Placental blood flow on the fetal side is
calculated to be approximately 0.35 mL min g−1 in vivo
at term, based on the placenta receiving 40% of fetal left
ventricular output, being 480 mL min−1 at term. This
compares to an ex vivo fetal-side flow of 0.17 mL min−1
based on a perfused tissue mass of 35 g being perfused
at 6 mL min−1 (Desforges et al. 2017). Once perfusion
is established, a number of experiments can be under-
taken that are not possible in vivo. Examples include
increasing or decreasing the flow rate of either fetal
or maternal perfusate, introducing drugs such as vaso-
dilators/constrictors, or multiple sampling to monitor
perfusate gases. There are disadvantages however: there
is a high preparation failure rate; it is reasonably expensive
and time-consuming to run an experiment; and only one
lobule from each placenta is usually suitably intact for
perfusion, preventing parallel control investigations.
To simplify our understanding of placental oxygen
transfer, a new adapted version of this model is being
trialled by our laboratory. This involves scaling down the
established maternal-side multi-cannula dual perfusion
model, so that the IVS irrigation volume is limited,
employing just onematernal cannula delivering normoxic
perfusate and measuring oxygen gradients within the
IVS (Fig. 2B). Unlike in vivo oxygen sampling, extensive
IVS oxygen sampling under steady-state experimental
conditions is possible by means of an oxygen-sensitive
needle optode inserted through the decidual plate at
set X–Y–Z planes controlled with a micromanipulator
(Fig. 2B). With further experimentation the placental
metabolic component of IVS oxygen consumption can be
elucidated. IVS oxygen gradient data can be acquired and
MVM
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2 μm 100 μm
1000 μm
Figure 3. Evaluating imaging techniques for
use in assessing placental structure
A, a transmission electron micrograph of terminal
villi showing microvillous membrane (MVM), an
underlying capillary (CAP), a syncytiotrophoblast
(S), a trophoblast (T) and endothelium (E). B,
projection of an imaged stack (wholemount
confocal microscopy), stained with lectin
FITC-AAL for the endothelium (green),
rhodamine-PSA for the stroma (red) and
biotin-DSL for the trophoblast (violet); the DSL
was detected with streptavidin 680 and imaging
was on a Leica Sp5 confocal microscope,
presented as an image stack. C, villous
microcirculation of a term normal placenta
perfused with a Ulex Europaeus Agglutinin (UEA)
lectin linked to biotin and detected with
streptavidin 800. D, microCT image of a vascular
corrosion cast of a term placenta, infused through
the umbilical artery with Batson’s resin, which was
then set, followed by tissue corrosion steps for
several days in 20% (w/v) potassium hydroxide.
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interrogated for metabolism and transfer, and it may be
possible to discover how variable perfusate flow rates and
fetoplacental vasoactive endocrine agents affect fetal-side
oxygen acquisition, gaining an understanding of how the
associated underlying villous architecture enhances or
constrains oxygen transfer across the placental barrier.
Post-perfused human placental tissue can be
successfully imaged using wholemount confocal and
light sheet microscopy. These 3-D approaches confer
advantages over traditional 2-D techniques such as
transmission-electron and phase-contrast microscopy
(Fig. 3A), and allow the surface of the villi and the fetal
vascular system to be differentially labelled (Fig. 3B and
C). However, these higher-resolution approaches are only
able to image smaller regions of tissue. Micro-computed
tomography (MicroCT) allows the visualisation of larger
regions of placental villi placenta but at different scales
(Fig. 3D). Imaging of the fetoplacental vascular system can
be enhanced by perfusing contrast agents into the fetal
circulation to image the arterial and venous circulation
(Junaid et al. 2017). From this, information on vessel
branching patterns, interbranching length and capillary
loop dilatations are useful in predicting the placenta’s
ability to optimally transfer oxygen, a portion of the
placenta often inaccessible by other means (Junaid et al.
2017). However, while microCT can image large regions
of tissue, when doing this its ability to image the micro-
circulation is limited. MicroCT imaging of fetoplacental
capillaries is possible but in smaller pieces of tissue.
Integrating structure and function relationships through
modelling. The increased availability of 3-D imaging
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Figure 4. Mathematical modelling of human placental perfusion and oxygenation at different scales
A, variability of perfusion in a fetoplacental vascular network (colour scale shows pressure for chorionic vessels
and relative capillary flow for terminal capillaries, plotted as spheres) (Clark et al. 2015). B, distribution of a passive
solute in the intervillous space of a single placental lobule (Chernyavsky et al. 2010). C, oxygen flux distribution over
the capillary and syncytiotrophoblast surfaces of a single terminal villus (Pearce et al. 2016). D, microscopic flow
in the intervillous space (Perazzolo et al. 2017). Images are reproduced with permission, subject to the respective
copyrights.
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approaches, including confocal microscopy andmicroCT,
have made possible the recent increase in efforts to build
multiscale computational models that go hand-in-hand
with refined experimental models (Pearce et al. 2016;
Plitman Mayo et al. 2016a; Perazzolo et al. 2017; Roth
et al. 2017) (Fig. 4). In tissues with complex structures
such as the human placenta, computational modelling
has allowed the full structure to be visualised and
analysed, facilitating assessment of structure–function
relationships (Clark et al. 2015; PlitmanMayo et al. 2016a)
(Fig. 4A). Mathematical models have also been created to
explain properties of the placenta that it would not be
possible to understand using in vivo measurements alone
(Chernyavsky et al. 2011; Serov et al. 2015; Pearce et al.
2016) (Fig. 4B–D). However, there is the open challenge
of effective extraction of structural information from
imaging data as well as of identifying key parameter values
necessary for mathematical modelling. Once validated,
theoretical models could provide a bridge between in vivo
and ex vivo or in vitro approaches to characterise placental
structure andoxygenation innormal andpathological pre-
gnancies (Lecarpentier et al. 2016).
Conclusion
The physiology of placental oxygen transfer is crucial for
optimal fetal development and survival. Gross placental
structure is well characterised and newer techniques, such
as MRI, microCT and advanced microscopy scanning
techniques, are affording greater detail. However, the
function of the placenta remains poorly understood. Key
measurements of oxygen and carbon dioxide levels in a
normal human placenta remain elusive due to logistical
and ethical complications with experimenting on in
vivo human placentas, which are compounded by slow
advances of ex vivo, in vitro and in silico work.
This lack of fundamental understanding has led to
slow progress in terms of treating pathological states such
as in cases of fetal growth restriction. It is our theory
that impaired placental oxygen transfer and metabolism
(Schneider, 2015) may well be a key factor in many
cases of FGR; however, whether this is due to abnormal
structure or abnormal function is currently unknown. It is
only with robust measures and consensus in experimental
design that we can develop an integrated understanding of
structure–function relationships within the placenta. This
in turn will provide a basis for developing therapeutic
interventions for the treatment of the placenta in fetal
diseases in vivo.
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